Geode Capital Management’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-111,185
| Closed | -$503K | – | 4539 |
|
|
2025
Q4 | $503K | Sell |
111,185
-115,312
| -51% | -$591K | ﹤0.01% | 3581 |
|
|
2025
Q3 | $1.22M | Sell |
226,497
-19,706
| -8% | -$107K | ﹤0.01% | 3319 |
|
|
2025
Q2 | $1.34M | Buy |
246,203
+27,377
| +13% | +$109K | ﹤0.01% | 3248 |
|
|
2025
Q1 | $606K | Sell |
218,826
-22,924
| -9% | -$79.8K | ﹤0.01% | 3475 |
|
|
2024
Q4 | $824K | Buy |
241,750
+22,491
| +10% | +$64.8K | ﹤0.01% | 3435 |
|
|
2024
Q3 | $645K | Sell |
219,259
-41,971
| -16% | -$138K | ﹤0.01% | 3514 |
|
|
2024
Q2 | $888K | Buy |
261,230
+52,316
| +25% | +$171K | ﹤0.01% | 3346 |
|
|
2024
Q1 | $633K | Buy |
208,914
+6,914
| +3% | +$24.3K | ﹤0.01% | 3526 |
|
|
2023
Q4 | $850K | Buy |
202,000
+2,670
| +1% | +$14.5K | ﹤0.01% | 3413 |
|
|
2023
Q3 | $1.36M | Buy |
199,330
+19,358
| +11% | +$171K | ﹤0.01% | 3205 |
|
|
2023
Q2 | $1.88M | Buy |
179,972
+12,770
| +8% | +$114K | ﹤0.01% | 3130 |
|
|
2023
Q1 | $1.17M | Buy |
167,202
+1,188
| +0.7% | +$10.4K | ﹤0.01% | 3275 |
|
|
2022
Q4 | $1M | Buy |
166,014
+14,192
| +9% | +$105K | ﹤0.01% | 3334 |
|
|
2022
Q3 | $1.2M | Buy |
151,822
+2,187
| +1% | +$25.5K | ﹤0.01% | 3299 |
|
|
2022
Q2 | $2.04M | Sell |
149,635
-167,141
| -53% | -$2.76M | ﹤0.01% | 3103 |
|
|
2022
Q1 | $6.21M | Buy |
316,776
+15,113
| +5% | +$302K | ﹤0.01% | 2666 |
|
|
2021
Q4 | $10.3M | Buy |
301,663
+9,376
| +3% | +$377K | ﹤0.01% | 2419 |
|
|
2021
Q3 | $16M | Buy |
292,287
+8,470
| +3% | +$510K | ﹤0.01% | 2117 |
|
|
2021
Q2 | $20.9M | Buy |
283,817
+144,331
| +103% | +$14.4M | ﹤0.01% | 1932 |
|
|
2021
Q1 | $12.8M | Buy |
139,486
+9,555
| +7% | +$927K | ﹤0.01% | 2189 |
|
|
2020
Q4 | $10.5M | Sell |
129,931
-947
| -0.7% | -$72.5K | ﹤0.01% | 2141 |
|
|
2020
Q3 | $6.09M | Buy |
+130,878
| New | +$7.3M | ﹤0.01% | 2275 |
|
Geode Capital Management's CVAC Position: Q1 2026 in Review
Geode Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 111,185 shares — an estimated $503K sold.
Geode Capital Management first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $20.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Geode Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 111,185 CureVac shares in Q1 2026, an estimated $503K.
- Geode Capital Management first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
- Geode Capital Management's CureVac position peaked at $20.9M in Q2 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.